Blaabjerg, L. M. | bioRxiv Science

bioRxiv2026

Effects of protein interface mutations on protein quality and affinity

Accurately modeling antibody-antigen interactions requires distinguishing intrinsic binding affinity ("protein-interaction") from protein biophysical properties ("protein-quality"), including folding, stability, and expression. However, high-throughput mutational measurements commonly used to train and benchmark computational models often conflate these effects, obscuring the true determinants of molecular recognition. Here, we present an experimental and analytical framework to disentangle protein-interaction effects from protein-quality effects in single-domain antibody (VHH)-antigen binding. Using a large-scale deep mutational scanning (DMS) dataset spanning four VHH-antigen complexes, with single and double mutations in both partners, we introduce control binders to quantify protein-quality changes independently of protein-interaction. This enables decomposition of experimentally measured affinity into protein-interaction and protein-quality components at scale. Leveraging the disentangled dataset, we evaluated state-of-the-art structure- and sequence-based models for protein-quality and protein-interaction prediction and show that their performance largely reflects protein-quality rather than protein-interaction effects. Our results highlight a major confounder in current datasets and suggest that accounting for protein-quality will be essential for training next-generation affinity-prediction models. Nomenclature Antibody related termsO_LIPrimary VHH: The VHH of a VHH-antigen complex for which the paratope and the epitope weremutated. C_LIO_LIControl VHH: A second VHH that binds to the same antigen as the primary VHH but has non-overlapping epitope positions and therefore does not bind to any of the mutated antigen positions. C_LI Affinity-related termsO_LIReal Affinity: "The strength of the interaction between two [...] molecules that bind reversibly (interact)" 1. In the context of antibody-antigen binding, it quantifies interactions between active proteins (which are expressed and correctly folded 2 and are therefore functionally and biologically active (see below). It is commonly quantified by the equilibrium dissociation constant, KD. C_LIO_LIObserved affinity ({degrees}KD): The interaction strength experimentally measured between two molecules. Unlike real affinity, this value is confounded by the biophysical properties of the individual binding partners, specifically their folding, stability, and expression levels. Consequently, the observed affinity often differs from the real/intrinsic affinity if a significant fraction of the protein population is inactive 3. NOTE: Unless otherwise specified, {degrees}KD is reported in - log10 space. For example, a {degrees}KD of -9 corresponds to 10-9M or 1nM. C_LIO_LIChange in observed affinity ({Delta}{degrees}KD): The shift in the observed affinity between two proteins upon mutation, reported as the log10-transformed fold change. A value of 1 reflects a 10-fold difference, a value of 2 a 100-fold difference, etc. This aggregate change resolves into two distinct biophysical components 2, 4: O_LIProtein-interaction change: The change in the intrinsic thermodynamic affinity between the two binding partners, each in its active state (i.e., the specific change in interface Gibbs free energy because both enthalpy and entropy are considered). C_LIO_LIProtein-quality change: The change in the fraction of the mutated protein population that is biologically active - meaning it is expressed, correctly folded, and stable 2, 5. O_LIFolding: The process that guides the polypeptide chain toward its native conformation, which is a prerequisite for forming a functional binding site. C_LIO_LIStability: The thermodynamic capacity to maintain the folded structure over time and under physiological conditions. Stability (decrease in Gibbs free energy from the unfolded to the folded state) ensures the binding interface remains intact and prevents competing processes such as aggregation 6. C_LIO_LIExpression: The steady-state abundance of the protein. This is largely dependent on proper folding and stability, as cellular quality control mechanisms degrade proteins that fail to fold or remain stable at functional concentrations. C_LI C_LI C_LIO_LIChange in relative affinity ({Delta}{Delta}{degrees}KD): the difference between the {Delta}{degrees}KD of the primary VHH compared to the control VHH for a given epitope mutation. C_LI Model-related termsO_LIESM-IF1 sc: Single-chain (sc) structure-conditioned inverse folding model (ESM-IF1), using the isolated monomer structure of the mutated protein: either the VHH or the antigen 7. C_LIO_LIESM-IF1 mc: Multi-chain (mc) structure-conditioned model (ESM-IF1), using the full complex structure (both antibody and antigen) 7. C_LIO_LIStability prediction score: Score that represents the predicted change in stability based on a single mutation, normally represented as {Delta}{Delta}G. C_LI

molecular biology↗

bioRxiv2025

Supervised learning of protein variant effects across large-scale mutagenesis datasets

The increasing availability of data from multiplexed assays of variant effects (MAVEs) enables supervised model training against large quantities of experimental data to learn sequence-function relationships. Variant effect scores from MAVEs can, however, be influenced by the experimental method to create experiment-to-experiment differences in the mapping from molecular level-variant effects to MAVE readout, which presents a challenge for supervised learning across datasets. We here propose a framework for performing supervised learning with MAVE data that takes the influence of the experimental protocol into account, thus enabling variant effects to be learned across datasets produced in independent experiments. We apply the framework to train a model against variant effect scores collected with VAMP-seq, a MAVE technique that quantifies the steady-state cellular abundance of protein variants. We show that mapping variant abundance to VAMP-seq readout in a dataset-specific manner during model training improves the learned abundance model and moreover allows the learned model to predict variant effects on an interpretable scale. Our work highlights the importance of validating MAVE results with low-throughput methods to facilitate MAVE score interpretation and supervised model training.

biophysics↗

bioRxiv2023

A joint embedding of protein sequence and structure enables robust variant effect predictions

The ability to predict how amino acid changes may affect protein function has a wide range of applications including in disease variant classification and protein engineering. Many existing methods focus on learning from patterns found in either protein sequences or protein structures. Here, we present a method for integrating information from protein sequences and structures in a single model that we term SSEmb (Sequence Structure Embedding). SSEmb combines a graph representation for the protein structure with a transformer model for processing multiple sequence alignments, and we show that by integrating both types of information we obtain a variant effect prediction model that is more robust to cases where sequence information is scarce. Furthermore, we find that SSEmb learns embeddings of the sequence and structural properties that are useful for other downstream tasks. We exemplify this by training a downstream model to predict protein-protein binding sites at high accuracy using only the SSEmb embeddings as input. We envisage that SSEmb may be useful both for zero-shot predictions of variant effects and as a representation for predicting protein properties that depend on protein sequence and structure.

bioinformatics↗

bioRxiv2022

Rapid protein stability prediction using deep learning representations

Predicting the thermodynamic stability of proteins is a common and widely used step in protein engineering, and when elucidating the molecular mechanisms behind evolution and disease. Here, we present RaSP, a method for making rapid and accurate predictions of changes in protein stability by leveraging deep learning representations. RaSP performs on-par with biophysics-based methods and enables saturation mutagenesis stability predictions in less than a second per residue. We use RaSP to calculate [~] 300 million stability changes for nearly all single amino acid changes in the human proteome, and examine variants observed in the human population. We find that variants that are common in the population are substantially depleted for severe destabilization, and that there are substantial differences between benign and pathogenic variants, highlighting the role of protein stability in genetic diseases. RaSP is freely available--including via a Web interface--and enables large-scale analyses of stability in experimental and predicted protein structures.

biophysics↗